Publications by authors named "M S Athiyamaan"
Article Synopsis
- Cervical cancer affects around 600,000 women globally each year, and this study focused on how treatment timing, specifically the gap between external beam radiotherapy and brachytherapy, impacts early recurrences.
- Data was collected from medical records of 288 cervical cancer patients, revealing that 93% had a complete response to treatment yet 8% experienced early cancer recurrences within six months.
- The research found a significant correlation between longer overall treatment times and increased risk of early recurrences, suggesting that optimizing treatment schedules could improve patient outcomes.
There has been growing interest in the use of epidermal growth factor receptor inhibitors in various cancers. The study was conducted to evaluate the efficacy and safety of gefitinib as a monotherapy in patients with recurrent or metastatic cervical cancer. Patients with cervical carcinoma who experienced locoregional recurrence or distant metastases either at presentation or after definitive combined chemoradiotherapy or postoperative radiotherapy were enrolled.
View Article and Find Full Text PDFBackground: To develop a dosimetric tool to estimate the dose delivered in the presence of air pockets with EBT3 film while simulating the conditions of vaginal vault brachytherapy (VVBT) with 3.0 diameter cylindrical applicator at a prescription dose distance of 5mm from the surface of it.
Materials And Method: Six acrylic plates (10 cm x 10 cm, 0.
Aim: To determine the effect of cochlear dose on sensorineural hearing loss in patients with head and neck cancer treated by radiotherapy and chemoradiotherapy.
Materials And Method: A two-year longitudinal study was conducted on 130 subjects with various head and neck malignancies who were receiving radiotherapy or chemoradiation. 56 patients received only radiotherapy while 74 patients received concurrent chemoradiation five days a week at a dose of 66-70 Gy.
Background: To assess and compare the local control and toxicities between HDR Intracavitary Brachytherapy with 7.5 Gy and 9 Gy per fraction after EBRT in treatment of carcinoma cervix.
Methodology: A total of 180 patients were randomly assigned to 2 arms.